APO Research
Talk to an analyst

APO RESEARCH · REPORT

Absorbable Hemostatic Agents

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Absorbable Hemostatic Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025196 pages

Choose your research edition.

Industry ResearchAbsorbable Hemostatic Agents Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Absorbable Hemostatic Agents Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Absorbable Hemostatic Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Absorbable Hemostatic Agents Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Absorbable Hemostatic Agents Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Absorbable Hemostatic Agents market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Absorbable Hemostatic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Absorbable Hemostatic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Absorbable Hemostatic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Absorbable Hemostatic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Absorbable Hemostatic Agents include BD, Biotemed, Cura Medical, Curasan AG, Foryou Medical, GELITA MEDICAL, Meril Life Sciences, Saikesaisi Holdings Group and Zhonghui Shengxi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Absorbable Hemostatic Agents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Absorbable Hemostatic Agents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Absorbable Hemostatic Agents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Absorbable Hemostatic Agents market size, projected growth trends, production technologies, key applications, and end-use industries.

Absorbable Hemostatic Agents Segment by Company

BD

Biotemed

Cura Medical

Curasan AG

Foryou Medical

GELITA MEDICAL

Meril Life Sciences

Saikesaisi Holdings Group

Zhonghui Shengxi

Baxter

Beijing Taikesiman

B.Braun

Beijing Datsing Bio-tech

Guizhou Jin Jiu Biotech

Johnson & Johnson

Absorbable Hemostatic Agents Segment by Type

Gauze

Gelatin Sponge

Powder

Other

Absorbable Hemostatic Agents Segment by Application

Hospital

Clinics

Others

Absorbable Hemostatic Agents Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Absorbable Hemostatic Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Absorbable Hemostatic Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Absorbable Hemostatic Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Absorbable Hemostatic Agents market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Absorbable Hemostatic Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Absorbable Hemostatic Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Absorbable Hemostatic Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Absorbable Hemostatic Agents Industry Trends Table 2. Absorbable Hemostatic Agents Industry Drivers Table 3. Absorbable Hemostatic Agents Industry Opportunities and Challenges Table 4. Absorbable Hemostatic Agents Industry Restraints Table 5. Global Absorbable Hemostatic Agents Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Absorbable Hemostatic Agents Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Absorbable Hemostatic Agents Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Absorbable Hemostatic Agents Sales Market Share by Manufacturers Table 9. Global Absorbable Hemostatic Agents Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Absorbable Hemostatic Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Absorbable Hemostatic Agents Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Absorbable Hemostatic Agents Manufacturers, Product Type & Application Table 13. Global Absorbable Hemostatic Agents Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Absorbable Hemostatic Agents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Gauze Table 17. Major Manufacturers of Gelatin Sponge Table 18. Major Manufacturers of Powder Table 19. Major Manufacturers of Other Table 20. Global Absorbable Hemostatic Agents Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Absorbable Hemostatic Agents Sales by Type (2021-2026) & (K Units) Table 22. Global Absorbable Hemostatic Agents Sales by Type (2027-2032) & (K Units) Table 23. Global Absorbable Hemostatic Agents Sales Market Share by Type (2021-2026) Table 24. Global Absorbable Hemostatic Agents Sales Market Share by Type (2027-2032) Table 25. Global Absorbable Hemostatic Agents Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Absorbable Hemostatic Agents Revenue by Type (2021-2026) & (K Units) Table 27. Global Absorbable Hemostatic Agents Revenue by Type (2027-2032) & (K Units) Table 28. Global Absorbable Hemostatic Agents Revenue Market Share by Type (2021-2026) Table 29. Global Absorbable Hemostatic Agents Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Clinics Table 32. Major Manufacturers of Others Table 33. Global Absorbable Hemostatic Agents Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Absorbable Hemostatic Agents Sales by Application (2021-2026) & (K Units) Table 35. Global Absorbable Hemostatic Agents Sales by Application (2027-2032) & (K Units) Table 36. Global Absorbable Hemostatic Agents Sales Market Share by Application (2021-2026) Table 37. Global Absorbable Hemostatic Agents Sales Market Share by Application (2027-2032) Table 38. Global Absorbable Hemostatic Agents Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Absorbable Hemostatic Agents Revenue by Application (2021-2026) & (K Units) Table 40. Global Absorbable Hemostatic Agents Revenue by Application (2027-2032) & (K Units) Table 41. Global Absorbable Hemostatic Agents Revenue Market Share by Application (2021-2026) Table 42. Global Absorbable Hemostatic Agents Revenue Market Share by Application (2027-2032) Table 43. Global Absorbable Hemostatic Agents Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Absorbable Hemostatic Agents Sales by Region (2021-2026) & (K Units) Table 45. Global Absorbable Hemostatic Agents Sales Market Share by Region (2021-2026) Table 46. Global Absorbable Hemostatic Agents Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Absorbable Hemostatic Agents Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Absorbable Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Absorbable Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 50. North America Absorbable Hemostatic Agents Sales by Country (2027-2032) & (K Units) Table 51. Europe Absorbable Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Absorbable Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 53. Europe Absorbable Hemostatic Agents Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Absorbable Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Absorbable Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Absorbable Hemostatic Agents Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Absorbable Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Absorbable Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Absorbable Hemostatic Agents Sales by Country (2027-2032) & (K Units) Table 60. Global Absorbable Hemostatic Agents Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Absorbable Hemostatic Agents Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Absorbable Hemostatic Agents Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Absorbable Hemostatic Agents Revenue Market Share by Region (2021-2026) Table 64. Global Absorbable Hemostatic Agents Revenue Market Share by Region (2027-2032) Table 65. BD Company Information Table 66. BD Business Overview Table 67. BD Absorbable Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. BD Absorbable Hemostatic Agents Product Portfolio Table 69. BD Recent Development Table 70. Biotemed Company Information Table 71. Biotemed Business Overview Table 72. Biotemed Absorbable Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Biotemed Absorbable Hemostatic Agents Product Portfolio Table 74. Biotemed Recent Development Table 75. Cura Medical Company Information Table 76. Cura Medical Business Overview Table 77. Cura Medical Absorbable Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Cura Medical Absorbable Hemostatic Agents Product Portfolio Table 79. Cura Medical Recent Development Table 80. Curasan AG Company Information Table 81. Curasan AG Business Overview Table 82. Curasan AG Absorbable Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Curasan AG Absorbable Hemostatic Agents Product Portfolio Table 84. Curasan AG Recent Development Table 85. Foryou Medical Company Information Table 86. Foryou Medical Business Overview Table 87. Foryou Medical Absorbable Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Foryou Medical Absorbable Hemostatic Agents Product Portfolio Table 89. Foryou Medical Recent Development Table 90. GELITA MEDICAL Company Information Table 91. GELITA MEDICAL Business Overview Table 92. GELITA MEDICAL Absorbable Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. GELITA MEDICAL Absorbable Hemostatic Agents Product Portfolio Table 94. GELITA MEDICAL Recent Development Table 95. Meril Life Sciences Company Information Table 96. Meril Life Sciences Business Overview Table 97. Meril Life Sciences Absorbable Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Meril Life Sciences Absorbable Hemostatic Agents Product Portfolio Table 99. Meril Life Sciences Recent Development Table 100. Saikesaisi Holdings Group Company Information Table 101. Saikesaisi Holdings Group Business Overview Table 102. Saikesaisi Holdings Group Absorbable Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Saikesaisi Holdings Group Absorbable Hemostatic Agents Product Portfolio Table 104. Saikesaisi Holdings Group Recent Development Table 105. Zhonghui Shengxi Company Information Table 106. Zhonghui Shengxi Business Overview Table 107. Zhonghui Shengxi Absorbable Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Zhonghui Shengxi Absorbable Hemostatic Agents Product Portfolio Table 109. Zhonghui Shengxi Recent Development Table 110. Baxter Company Information Table 111. Baxter Business Overview Table 112. Baxter Absorbable Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Baxter Absorbable Hemostatic Agents Product Portfolio Table 114. Baxter Recent Development Table 115. Beijing Taikesiman Company Information Table 116. Beijing Taikesiman Business Overview Table 117. Beijing Taikesiman Absorbable Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Beijing Taikesiman Absorbable Hemostatic Agents Product Portfolio Table 119. Beijing Taikesiman Recent Development Table 120. B.Braun Company Information Table 121. B.Braun Business Overview Table 122. B.Braun Absorbable Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. B.Braun Absorbable Hemostatic Agents Product Portfolio Table 124. B.Braun Recent Development Table 125. Beijing Datsing Bio-tech Company Information Table 126. Beijing Datsing Bio-tech Business Overview Table 127. Beijing Datsing Bio-tech Absorbable Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Beijing Datsing Bio-tech Absorbable Hemostatic Agents Product Portfolio Table 129. Beijing Datsing Bio-tech Recent Development Table 130. Guizhou Jin Jiu Biotech Company Information Table 131. Guizhou Jin Jiu Biotech Business Overview Table 132. Guizhou Jin Jiu Biotech Absorbable Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Guizhou Jin Jiu Biotech Absorbable Hemostatic Agents Product Portfolio Table 134. Guizhou Jin Jiu Biotech Recent Development Table 135. Johnson & Johnson Company Information Table 136. Johnson & Johnson Business Overview Table 137. Johnson & Johnson Absorbable Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Johnson & Johnson Absorbable Hemostatic Agents Product Portfolio Table 139. Johnson & Johnson Recent Development Table 140. Key Raw Materials Table 141. Raw Materials Key Suppliers Table 142. Absorbable Hemostatic Agents Distributors List Table 143. Absorbable Hemostatic Agents Customers List Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Absorbable Hemostatic Agents Product Image Figure 2. Global Absorbable Hemostatic Agents Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Absorbable Hemostatic Agents Market Size (2021-2032) & (US$ Million) Figure 4. Global Absorbable Hemostatic Agents Sales (2021-2032) & (K Units) Figure 5. Global Absorbable Hemostatic Agents Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Absorbable Hemostatic Agents Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Gauze Image Figure 9. Gelatin Sponge Image Figure 10. Powder Image Figure 11. Other Image Figure 12. Global Absorbable Hemostatic Agents Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Absorbable Hemostatic Agents Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Absorbable Hemostatic Agents Sales Market Share by Type (2021-2032) Figure 15. Global Absorbable Hemostatic Agents Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Absorbable Hemostatic Agents Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Absorbable Hemostatic Agents Revenue Market Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinics Image Figure 20. Others Image Figure 21. Global Absorbable Hemostatic Agents Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Absorbable Hemostatic Agents Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Absorbable Hemostatic Agents Sales Market Share by Application (2021-2032) Figure 24. Global Absorbable Hemostatic Agents Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Absorbable Hemostatic Agents Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Absorbable Hemostatic Agents Revenue Market Share by Application (2021-2032) Figure 27. North America Absorbable Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Absorbable Hemostatic Agents Sales Market Share by Country (2021-2032) Figure 29. U.S. Absorbable Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Absorbable Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Absorbable Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Absorbable Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Absorbable Hemostatic Agents Sales Market Share by Country (2021-2032) Figure 34. Germany Absorbable Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Absorbable Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Absorbable Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Absorbable Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Absorbable Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Absorbable Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Absorbable Hemostatic Agents Sales Market Share by Country (2021-2032) Figure 41. China Absorbable Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Absorbable Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Absorbable Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Absorbable Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Absorbable Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Absorbable Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Absorbable Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Absorbable Hemostatic Agents Sales Market Share by Country (2021-2032) Figure 49. Brazil Absorbable Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Absorbable Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Absorbable Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Absorbable Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Absorbable Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Absorbable Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Absorbable Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Absorbable Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Absorbable Hemostatic Agents Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Absorbable Hemostatic Agents Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Absorbable Hemostatic Agents Revenue (2021-2032) & (US$ Million) Figure 60. North America Absorbable Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Absorbable Hemostatic Agents Revenue (2021-2032) & (US$ Million) Figure 62. Europe Absorbable Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Absorbable Hemostatic Agents Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Absorbable Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Absorbable Hemostatic Agents Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Absorbable Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Absorbable Hemostatic Agents Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Absorbable Hemostatic Agents Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Gauze
  • Gelatin Sponge
  • Powder
  • Other
Applications
  • Hospital
  • Clinics
  • Others
Companies covered
  • BD
  • Biotemed
  • Cura Medical
  • Curasan AG
  • Foryou Medical
  • GELITA MEDICAL
  • Meril Life Sciences
  • Saikesaisi Holdings Group
  • Zhonghui Shengxi
  • Baxter
  • Beijing Taikesiman
  • B.Braun
  • Beijing Datsing Bio-tech
  • Guizhou Jin Jiu Biotech
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Absorbable Hemostatic Agents Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Absorbable Hemostatic Agents Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Absorbable Hemostatic Agents Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Absorbable Hemostatic Agents Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Absorbable Hemostatic Agents Market Dynamics
  1. 2.1 Absorbable Hemostatic Agents Industry Trends
  2. 2.2 Absorbable Hemostatic Agents Industry Drivers
  3. 2.3 Absorbable Hemostatic Agents Industry Opportunities and Challenges
  4. 2.4 Absorbable Hemostatic Agents Industry Restraints
3 Absorbable Hemostatic Agents Market by Manufacturers
  1. 3.1 Global Absorbable Hemostatic Agents Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Absorbable Hemostatic Agents Sales by Manufacturers (2021-2026)
  3. 3.3 Global Absorbable Hemostatic Agents Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Absorbable Hemostatic Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Absorbable Hemostatic Agents Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Absorbable Hemostatic Agents Manufacturers, Product Type & Application
  7. 3.7 Global Absorbable Hemostatic Agents Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Absorbable Hemostatic Agents Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Absorbable Hemostatic Agents Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Absorbable Hemostatic Agents Tier 1, Tier 2, and Tier 3
4 Absorbable Hemostatic Agents Market by Type
  1. 4.1 Absorbable Hemostatic Agents Type Introduction
  2. 4.1.1 Gauze
  3. 4.1.2 Gelatin Sponge
  4. 4.1.3 Powder
  5. 4.1.4 Other
  6. 4.2 Global Absorbable Hemostatic Agents Sales by Type
  7. 4.2.1 Global Absorbable Hemostatic Agents Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Absorbable Hemostatic Agents Sales by Type (2021-2032)
  9. 4.2.3 Global Absorbable Hemostatic Agents Sales Market Share by Type (2021-2032)
  10. 4.3 Global Absorbable Hemostatic Agents Revenue by Type
  11. 4.3.1 Global Absorbable Hemostatic Agents Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Absorbable Hemostatic Agents Revenue by Type (2021-2032)
  13. 4.3.3 Global Absorbable Hemostatic Agents Revenue Market Share by Type (2021-2032)
5 Absorbable Hemostatic Agents Market by Application
  1. 5.1 Absorbable Hemostatic Agents Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Absorbable Hemostatic Agents Sales by Application
  6. 5.2.1 Global Absorbable Hemostatic Agents Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Absorbable Hemostatic Agents Sales by Application (2021-2032)
  8. 5.2.3 Global Absorbable Hemostatic Agents Sales Market Share by Application (2021-2032)
  9. 5.3 Global Absorbable Hemostatic Agents Revenue by Application
  10. 5.3.1 Global Absorbable Hemostatic Agents Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Absorbable Hemostatic Agents Revenue by Application (2021-2032)
  12. 5.3.3 Global Absorbable Hemostatic Agents Revenue Market Share by Application (2021-2032)
6 Global Absorbable Hemostatic Agents Sales by Region
  1. 6.1 Global Absorbable Hemostatic Agents Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Absorbable Hemostatic Agents Sales by Region (2021-2032)
  3. 6.2.1 Global Absorbable Hemostatic Agents Sales by Region (2021-2026)
  4. 6.2.2 Global Absorbable Hemostatic Agents Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Absorbable Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Absorbable Hemostatic Agents Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Absorbable Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Absorbable Hemostatic Agents Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Absorbable Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Absorbable Hemostatic Agents Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Absorbable Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Absorbable Hemostatic Agents Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Absorbable Hemostatic Agents Revenue by Region
  1. 7.1 Global Absorbable Hemostatic Agents Revenue by Region
  2. 7.1.1 Global Absorbable Hemostatic Agents Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Absorbable Hemostatic Agents Revenue by Region (2021-2026)
  4. 7.1.3 Global Absorbable Hemostatic Agents Revenue by Region (2027-2032)
  5. 7.1.4 Global Absorbable Hemostatic Agents Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Absorbable Hemostatic Agents Revenue (2021-2032)
  8. 7.2.2 North America Absorbable Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Absorbable Hemostatic Agents Revenue (2021-2032)
  11. 7.3.2 Europe Absorbable Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Absorbable Hemostatic Agents Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Absorbable Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Absorbable Hemostatic Agents Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Absorbable Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 BD
  2. 8.1.1 BD Company Information
  3. 8.1.2 BD Business Overview
  4. 8.1.3 BD Absorbable Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BD Absorbable Hemostatic Agents Product Portfolio
  6. 8.1.5 BD Recent Developments
  7. 8.2 Biotemed
  8. 8.2.1 Biotemed Company Information
  9. 8.2.2 Biotemed Business Overview
  10. 8.2.3 Biotemed Absorbable Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Biotemed Absorbable Hemostatic Agents Product Portfolio
  12. 8.2.5 Biotemed Recent Developments
  13. 8.3 Cura Medical
  14. 8.3.1 Cura Medical Company Information
  15. 8.3.2 Cura Medical Business Overview
  16. 8.3.3 Cura Medical Absorbable Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cura Medical Absorbable Hemostatic Agents Product Portfolio
  18. 8.3.5 Cura Medical Recent Developments
  19. 8.4 Curasan AG
  20. 8.4.1 Curasan AG Company Information
  21. 8.4.2 Curasan AG Business Overview
  22. 8.4.3 Curasan AG Absorbable Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Curasan AG Absorbable Hemostatic Agents Product Portfolio
  24. 8.4.5 Curasan AG Recent Developments
  25. 8.5 Foryou Medical
  26. 8.5.1 Foryou Medical Company Information
  27. 8.5.2 Foryou Medical Business Overview
  28. 8.5.3 Foryou Medical Absorbable Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Foryou Medical Absorbable Hemostatic Agents Product Portfolio
  30. 8.5.5 Foryou Medical Recent Developments
  31. 8.6 GELITA MEDICAL
  32. 8.6.1 GELITA MEDICAL Company Information
  33. 8.6.2 GELITA MEDICAL Business Overview
  34. 8.6.3 GELITA MEDICAL Absorbable Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GELITA MEDICAL Absorbable Hemostatic Agents Product Portfolio
  36. 8.6.5 GELITA MEDICAL Recent Developments
  37. 8.7 Meril Life Sciences
  38. 8.7.1 Meril Life Sciences Company Information
  39. 8.7.2 Meril Life Sciences Business Overview
  40. 8.7.3 Meril Life Sciences Absorbable Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Meril Life Sciences Absorbable Hemostatic Agents Product Portfolio
  42. 8.7.5 Meril Life Sciences Recent Developments
  43. 8.8 Saikesaisi Holdings Group
  44. 8.8.1 Saikesaisi Holdings Group Company Information
  45. 8.8.2 Saikesaisi Holdings Group Business Overview
  46. 8.8.3 Saikesaisi Holdings Group Absorbable Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Saikesaisi Holdings Group Absorbable Hemostatic Agents Product Portfolio
  48. 8.8.5 Saikesaisi Holdings Group Recent Developments
  49. 8.9 Zhonghui Shengxi
  50. 8.9.1 Zhonghui Shengxi Company Information
  51. 8.9.2 Zhonghui Shengxi Business Overview
  52. 8.9.3 Zhonghui Shengxi Absorbable Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Zhonghui Shengxi Absorbable Hemostatic Agents Product Portfolio
  54. 8.9.5 Zhonghui Shengxi Recent Developments
  55. 8.10 Baxter
  56. 8.10.1 Baxter Company Information
  57. 8.10.2 Baxter Business Overview
  58. 8.10.3 Baxter Absorbable Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Baxter Absorbable Hemostatic Agents Product Portfolio
  60. 8.10.5 Baxter Recent Developments
  61. 8.11 Beijing Taikesiman
  62. 8.11.1 Beijing Taikesiman Company Information
  63. 8.11.2 Beijing Taikesiman Business Overview
  64. 8.11.3 Beijing Taikesiman Absorbable Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Beijing Taikesiman Absorbable Hemostatic Agents Product Portfolio
  66. 8.11.5 Beijing Taikesiman Recent Developments
  67. 8.12 B.Braun
  68. 8.12.1 B.Braun Company Information
  69. 8.12.2 B.Braun Business Overview
  70. 8.12.3 B.Braun Absorbable Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 B.Braun Absorbable Hemostatic Agents Product Portfolio
  72. 8.12.5 B.Braun Recent Developments
  73. 8.13 Beijing Datsing Bio-tech
  74. 8.13.1 Beijing Datsing Bio-tech Company Information
  75. 8.13.2 Beijing Datsing Bio-tech Business Overview
  76. 8.13.3 Beijing Datsing Bio-tech Absorbable Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Beijing Datsing Bio-tech Absorbable Hemostatic Agents Product Portfolio
  78. 8.13.5 Beijing Datsing Bio-tech Recent Developments
  79. 8.14 Guizhou Jin Jiu Biotech
  80. 8.14.1 Guizhou Jin Jiu Biotech Company Information
  81. 8.14.2 Guizhou Jin Jiu Biotech Business Overview
  82. 8.14.3 Guizhou Jin Jiu Biotech Absorbable Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Guizhou Jin Jiu Biotech Absorbable Hemostatic Agents Product Portfolio
  84. 8.14.5 Guizhou Jin Jiu Biotech Recent Developments
  85. 8.15 Johnson & Johnson
  86. 8.15.1 Johnson & Johnson Company Information
  87. 8.15.2 Johnson & Johnson Business Overview
  88. 8.15.3 Johnson & Johnson Absorbable Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Johnson & Johnson Absorbable Hemostatic Agents Product Portfolio
  90. 8.15.5 Johnson & Johnson Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Absorbable Hemostatic Agents Value Chain Analysis
  2. 9.1.1 Absorbable Hemostatic Agents Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Absorbable Hemostatic Agents Production Mode & Process
  6. 9.2 Absorbable Hemostatic Agents Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Absorbable Hemostatic Agents Distributors
  9. 9.2.3 Absorbable Hemostatic Agents Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst